AUTO THERM 390, MODEL ME 390
Device Facts
| Record ID | K042554 |
|---|---|
| Device Name | AUTO THERM 390, MODEL ME 390 |
| Applicant | Mettler Electronics Corp. |
| Product Code | IMJ · Physical Medicine |
| Decision Date | Oct 8, 2004 |
| Decision | SESE |
| Submission Type | Abbreviated |
| Regulation | 21 CFR 890.5290 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Shortwave diathermy delivers energy in the radio band of 27.12 MHz to provide deep heating therapeutic effects to body tissues. When shortwave diathermy is delivered at intensities capable of generating a deep tissue temperature increase, it can be used for the treatment of many conditions such as: 1. Relieving pain 2. Reducing muscle spasm 3. Increasing range of motion of contracted joints using heat and stretch techniques. 4. Increasing blood flow to tissues in the treatment area.
Device Story
Auto*Therm 390 is a portable shortwave diathermy device operating at 27.12 MHz; utilizes condenser and electromagnetic inductive coil fields for continuous or pulsed therapy. Used in clinics and medical practices by clinicians to provide deep tissue heating. Device features membrane control panel, intensity encoder, and patient emergency-OFF switch. Output power is delivered via applicators connected to rear sockets. Therapy aims to relieve pain, reduce muscle spasms, increase blood flow, and improve joint range of motion. Portable design allows transport between treatment rooms; optional four-wheel cart with locking brakes available for induction electrode use.
Clinical Evidence
No clinical data provided; substantial equivalence is based on technological characteristics and intended use compared to the predicate device.
Technological Characteristics
Shortwave diathermy device operating at 27.12 MHz. Employs condenser and electromagnetic inductive coil fields. Modes: continuous and pulsed. Form factor: portable unit with membrane control panel. Connectivity: manual intensity control via encoder. Power: mains supply with external fuses. Safety: patient emergency-OFF switch.
Indications for Use
Indicated for patients requiring deep tissue heating for pain relief, reduction of muscle spasms, increased range of motion of contracted joints, and localized increase in blood flow.
Regulatory Classification
Identification
A nonthermal shortwave therapy is a prescription device that applies to the body pulsed electromagnetic energy in the RF bands of 13.56 MHz or 27.12 MHz and that is intended for adjunctive use in the palliative treatment of postoperative pain and edema of soft tissue by means other than the generation of deep heat within body tissues as described in paragraph (a) of this section.
Special Controls
*Classification: Class II (special controls).* The device is classified as class II. The special controls for this device are:(i) Components of the device that come into human contact must be demonstrated to be biocompatible. (ii) Appropriate analysis/testing must demonstrate that the device is electrically safe and electromagnetically compatible in its intended use environment. (iii) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. Non-clinical performance testing must characterize the output waveform of the device and demonstrate that the device meets appropriate output performance specifications. The output characteristics and the methods used to determine these characteristics, including the following, must be determined: (A) Peak output power; (B) Pulse width; (C) Pulse frequency; (D) Duty cycle; (E) Characteristics of other types of modulation that may be used; (F) Average measured output powered into the RF antenna/applicator; (G) Specific absorption rates in saline gel test load or other appropriate model; (H) Characterization of the electrical and magnetic fields in saline gel test load or other appropriate model for each RF antenna and prescribed RF antenna orientation/position; and (I) Characterization of the deposited energy density in saline gel test load or other appropriate model. (iv) A detailed summary of the clinical testing pertinent to use of the device to demonstrate the effectiveness of the device in its intended use. (v) Labeling must include the following: (A) Output characteristics of the device; (B) Recommended treatment regimes, including duration of use; and (C) A detailed summary of the clinical testing pertinent to the use of the device and a summary of the adverse events and complications. (vi) Nonthermal shortwave therapy devices marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with these special controls.
Predicate Devices
- Auto*Therm 395, Model 395